{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:56:38Z","timestamp":1774677398008,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.2353\/ajpath.2009.080799","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T01:56:43Z","timestamp":1242352603000},"page":"2150-2159","source":"Crossref","is-referenced-by-count":32,"title":["The Methylation of the TSC2 Promoter Underlies the Abnormal Growth of TSC2 Angiomyolipoma-Derived Smooth Muscle Cells"],"prefix":"10.1016","volume":"174","author":[{"given":"Elena","family":"Lesma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Maria","family":"Sirchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephana","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Bosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Ghelma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Di Giulio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Gorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2009.080799_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1357-4310(98)01245-3","article-title":"The genetic basis of tuberous sclerosis","volume":"4","author":"Young","year":"1998","journal-title":"Mol Med Today"},{"key":"10.2353\/ajpath.2009.080799_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1071-9091(98)80005-3","article-title":"Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex","volume":"5","author":"Neumann","year":"1998","journal-title":"Semin Pediatr Neurol"},{"key":"10.2353\/ajpath.2009.080799_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.080799_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.2353\/ajpath.2009.080799_bib5","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.080799_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Garami","year":"2003","journal-title":"Mol Cell"},{"key":"10.2353\/ajpath.2009.080799_bib7","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2009.080799_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2009.080799_bib9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","article-title":"Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation","volume":"63","author":"Chan","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.2353\/ajpath.2009.080799_bib10","first-page":"400","article-title":"Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions","volume":"59","author":"Henske","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.2353\/ajpath.2009.080799_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/321972","article-title":"Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions","volume":"69","author":"Niida","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.2353\/ajpath.2009.080799_bib12","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1086\/302648","article-title":"Complete inactivation of the TSC2 gene leads to formation of hamartomas","volume":"65","author":"Au","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.2353\/ajpath.2009.080799_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s004390000348","article-title":"Molecular genetic advances in tuberous sclerosis complex","volume":"107","author":"Cheadle","year":"2000","journal-title":"Hum Genet"},{"key":"10.2353\/ajpath.2009.080799_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0959-437X(99)80024-0","article-title":"DNA methylation and chromatin modification","volume":"9","author":"Ng","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"10.2353\/ajpath.2009.080799_bib15","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1093\/emboj\/17.17.4905","article-title":"CpG methylation, chromatin structure and gene silencing-a three-way connection","volume":"17","author":"Razin","year":"1998","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2009.080799_bib16","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/0008-5472.CAN-04-3840","article-title":"Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis","volume":"65","author":"El-Hashemite","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080799_bib17","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1158\/0008-5472.CAN-07-1356","article-title":"TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis","volume":"67","author":"Pacheco-Rodriguez","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080799_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: EGF is the required growth factor","volume":"167","author":"Lesma","year":"2005","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.080799_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2119\/2006-00091.Carelli","article-title":"Survivin expression in tuberous sclerosis complex cells","volume":"13","author":"Carelli","year":"2007","journal-title":"Mol Med"},{"key":"10.2353\/ajpath.2009.080799_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)61720-8","article-title":"The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma","volume":"159","author":"Arbiser","year":"2001","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.080799_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s004390000316","article-title":"Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis","volume":"106","author":"Jones","year":"2000","journal-title":"Hum Genet"},{"key":"10.2353\/ajpath.2009.080799_bib22","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.96.24.13825","article-title":"Promoter-specific hypoacetylation of X-inactivated genes","volume":"96","author":"Gilbert","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080799_bib23","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/sj.onc.1203456","article-title":"Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor \u03b22 promoter in breast cancer cells","volume":"19","author":"Sirchia","year":"2000","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.080799_bib24","first-page":"2455","article-title":"Endogenous reactivation of the RAR beta2 tumor suppressor gene epigenetically silenced in breast cancer","volume":"62","author":"Sirchia","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080799_bib25","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-04-3465","article-title":"Loss of the inactive X chromosome and replication of the active X in BRCA1 effective and wild-type breast cancer cells","volume":"65","author":"Sirchia","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080799_bib26","doi-asserted-by":"crossref","first-page":"e3558","DOI":"10.1371\/journal.pone.0003558","article-title":"Anti-EGFR antibody efficiently and specifically inhibits human TSC2-\/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM","volume":"3","author":"Lesma","year":"2008","journal-title":"PLoSONE"},{"key":"10.2353\/ajpath.2009.080799_bib27","first-page":"1639","article-title":"Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of the tuberous sclerosis tumors","volume":"151","author":"Henske","year":"1997","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.080799_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","article-title":"The drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation","volume":"105","author":"Tapon","year":"2001","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.080799_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1383-5742(01)00058-8","article-title":"Tuberous sclerosis gene products in proliferation control","volume":"488","author":"Hengstschl\u00e4ger","year":"2001","journal-title":"Mutat Res"},{"key":"10.2353\/ajpath.2009.080799_bib30","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080799_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/hmg\/9.3.447","article-title":"Genetic evidence for a trans-heterozygous model for cytogenesis in autosomal dominant polycystic kidney disease","volume":"9","author":"Koptides","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.2353\/ajpath.2009.080799_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nm0795-686","article-title":"5\u2032 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers","volume":"1","author":"Merlo","year":"1995","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.080799_bib33","first-page":"3034","article-title":"Epigenetic down-regulation of death-associated protein kinase in lung cancers","volume":"9","author":"Toyooka","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2009.080799_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1111098","article-title":"DNA modification mechanism and gene activity during development","volume":"187","author":"Holliday","year":"1975","journal-title":"Science"},{"key":"10.2353\/ajpath.2009.080799_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","article-title":"Alterations in DNA methylation: a fundamental aspect of neoplasia","volume":"72","author":"Baylin","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.2353\/ajpath.2009.080799_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","article-title":"Cancer epigenetics come to age","volume":"21","author":"Jones","year":"1999","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2009.080799_bib37","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","article-title":"Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes","volume":"41","author":"Jiang","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.2353\/ajpath.2009.080799_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-8-163","article-title":"Involvement of TSC genes and differential expression of other members of the mTOR signalling pathway in oral squamous cell carcinoma","volume":"8","author":"Chakraborty","year":"2008","journal-title":"BMC Cancer"},{"key":"10.2353\/ajpath.2009.080799_bib39","first-page":"285","article-title":"The molecular mechanism of HDAC inhibitors in anticancer effects","volume":"3","author":"Bi","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.2353\/ajpath.2009.080799_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to varinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.2353\/ajpath.2009.080799_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"5 Suppl 2","key":"10.2353\/ajpath.2009.080799_bib42","first-page":"15","article-title":"Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers","volume":"20","author":"Vokes","year":"2006","journal-title":"Oncology"},{"key":"10.2353\/ajpath.2009.080799_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse model","volume":"42","author":"Lee","year":"2005","journal-title":"Genes Chromosom Cancer"},{"key":"10.2353\/ajpath.2009.080799_bib44","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neural model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010610747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010610747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T23:24:00Z","timestamp":1545261840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010610747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0002944010610747"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2009.080799","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}